Joint Stock Company "Farmak"

• NCT05125640

  Phase 1, Completed, 48 people, 18 Nov 2021

• NCT05125627

  Phase 1, Completed, 66 people, 18 Nov 2021

• NCT05124717

  Phase 1, Completed, 28 people, 18 Nov 2021

• Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.

  Phase 1, Completed, 32 people, 17 Nov 2021

Sources: clinicaltrials.gov